Association between conformational mutations in neuroserpin and onset and severity of dementia

Lancet

Volumn 359, Issue 9325, 2002, Pages 2242-2247

  Davis, Richard L ^a   Shrimpton, Antony E ^a   Carrell, Robin W ^b   Lomas, David A ^b,c   Gerhard, Lieselotte ^d   Baumann, Bruno ^e   Lawrence, Daniel A ^f   Yepes, Manuel ^f,g   Kim, Tai Seung ^h   Ghetti, Bernardino ⁱ   Piccardo, Pedro ⁱ   Takao, Masaki ⁱ   Lacbawan, Felicitas ^j,k   Muenke, Maximilian ^k   Sifers, Richard N ^l   Bradshaw, Charles B ^a   Kent, Paul F ^a   Collins, George H ^a   Larocca, Daria ^a   Holohan, Peter D ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF WITTEN HERDECKE   (Germany)

^e OTTO VON GUERICKE UNIVERSITY   (Germany)

^f HOLLAND LABORATORY   (United States)

^g GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^h Yonsei University   (South Korea)

ⁱ INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^k NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^l BAYLOR COLLEGE OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUTOPSY; BIOAVAILABILITY; BIOPSY; BLOOD SAMPLING; BRAIN REGION; CONFORMATION; CONTROLLED STUDY; DEGENERATIVE DISEASE; DEMENTIA; DISEASE COURSE; DISEASE SEVERITY; EXTRACTION; GENE MUTATION; GENE SEQUENCE; HETEROZYGOSITY; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOLECULAR BIOLOGY; NERVE CELL; NERVE DEGENERATION; ONSET AGE; PRIORITY JOURNAL; PROTEIN STRUCTURE; TECHNIQUE; TOPOGRAPHY;

EID: 0037193809     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)09293-0     Document Type: Article

References (33)

1. Aggregates in neurodegenerative disease: Crowds and power?
2. The cerebral proteopathies
3. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: Implications for Parkinson's disease
4. Tau gene mutation G389R causes a tauopathy with abundant pick body-like inclusions and axonal deposits
5. Familial dementia caused by polymerisation of mutant neuroserpin
6. Familial encephalopathy with neuroserpin inclusions bodies
7. Biochemical characterization of a neuroserpin variant associated with hereditary dementia
8. Neuroserpin, an axonally secreted serine protease inhibitor
9. Neuroserpin, a brain-associated inhibitor of tissue plasminogen activator is localized primarily in neurons: Implications for the regulation of motor learning and neuronal survival
10. Crystal structure of neuroserpin: A neuronal serpin involved in a conformational disease
11. The serpins are an expanding superfamily of structurally similar but functionally diverse proteins: Evolution, mechanism of inhibition, novel functions, and a revised nomenclature
12. The mechanism of Z α1-antitrypsin accumulation in the liver
13. 53→Phe); Further evidence for intracellular loop-sheet polymerisation
14. Alpha1-antitrypsin deficiency: A model for conformational diseases
15. What do dysfunctional serpins tell us about molecular mobility and disease?
16. Conformational changes in serpins, I: The native and cleaved conformations of alpha(1)-antitrypsin
17. Neuroserpin mutation S52R causes neuroserpin accumulation in neurons and is associated with progressive myoclonus epilepsy
18. Mutant neuroserpin (S49P) that causes familial encephalopathy with neuroserpin inclusion bodies is a poor proteinase inhibitor and readily forms polymers in vitro
19. The native strains in the hydrophobic core and flexible reactive loop of a serine protease inhibitor: Crystal structure of an uncleaved alpha1-antitrypsin at 2.7 Å
20. Antithrombin-Gly 424 Arg: A novel point mutation responsible for type 1 antithrombin deficiency and neonatal thrombosis
21. Myoklonuskorperkrankheit und progressive myoklonusepilepsie
22. Zur klinischen und morphologischen Differential-diagnose der progressiven Myoklonusepilepsie bei Myoklonuskoeperkrankheitin
23. Cognitive deficits associated with a recently reported familial neurodegenerative disease: Familial encephalopathy with neuroserpin inclusion bodies
24. Progressive dementia and epilepsy in a young adult: Unusual intraneuronal inclusions
25. Myoclonus in neuronal storage and Lafora diseases
26. Myoclonus from selective dentate nucleus degeneration in type 3 Gaucher disease
27. Conformational diseases
28. Impairment of the ubiquitin-proteasome system by protein aggregation
29. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins
30. The cellular origin of amyloid: Electron microscopic study in a case of amyloidosis
31. Distinct sites of intracellular production for Alzheimer's disease Abeta40/42 amyloid peptides
32. Intracellular APP processing and A beta production in Alzheimer disease